title: Incidence of Fitz-Hugh-Curtis syndrome in adolescents who have pelvic inflammatory disease.
abstract: OBJECTIVE
  We determined the incidence of Fitz-Hugh-Curtis syndrome (FHCS) in adolescents who had mild to moderately severe pelvic inflammatory disease (PID).
  
  
  METHODS
  Prospective cohort study.
  
  
  METHODS
  Harris County Juvenile Detention Center, April 2000-April 2006.
  
  
  METHODS
  Incarcerated female adolescents.
  
  
  METHODS
  In patients who met accepted criteria for the diagnosis of PID, we determined the proportion that had right upper quadrant pain that responded to therapy for PID. They were diagnosed as having FHCS.
  
  
  RESULTS
  The 117 subjects' mean age (SD) was 15.6 (1.8) years; 37% were Hispanic, 34% black, and 26% white. 5/117 (4.3%, 95% confidence interval 1.4-9.7%) had symptomatic FHCS. Fifteen (13%) of all subjects, including 1 with FHCS, had fever and/or nausea and vomiting (moderately severe PID): none had generalized peritonitis or tubo-ovarian abscess (severe PID). Thirty-four had chlamydial, 4 gonorrheal, and 9 combined infections. All improved with standard outpatient PID therapy.
  
  
  CONCLUSIONS
  FHCS was uncommon (4%) in adolescents who had mild to moderate PID and chlamydia as the most common pathogen.
authors.affiliation: University of Texas--Houston Medical School, Houston, Texas 77030, USA. William.L.Risser@uth.tmc.edu
authors.forename: W L
authors.initials: WL
authors.lastname: Risser
authors.forename: J M
authors.initials: JM
authors.lastname: Risser
authors.forename: L J
authors.initials: LJ
authors.lastname: Benjamins
authors.forename: J M
authors.initials: JM
authors.lastname: Feldmann
mesh_terms: D000293:Adolescent; D015331:Cohort Studies; D005260:Female; D006505:Hepatitis / Q000150:complications* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D000292:Pelvic Inflammatory Disease / Q000150:complications*; D011329:Prisoners; D011446:Prospective Studies; D013577:Syndrome; D013781:Texas / Q000453:epidemiology; D000267:Tissue Adhesions / Q000150:complications* / Q000453:epidemiology